Larimar Therapeutics (LRMR) Total Liabilities (2013 - 2026)
Larimar Therapeutics (LRMR) recorded Total Liabilities of $37.92 million in Q2 2026, up 25.8% from $30.13 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Total Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Larimar Therapeutics reported Total Liabilities of $67.76 million, up 138.5% from FY2024.
- Annual Total Liabilities has a five-year compound annual growth rate of 35.2% (FY2020 to FY2025).
- Across earlier years, Total Liabilities came in at $28.41 million in FY2024 (+99.9%), $14.22 million in FY2023 (-8.3%), $15.5 million in FY2022 (+8.8%) and $14.25 million in FY2021 (-4.9%).
- Quarterly Total Liabilities has ranged from $11.24 million in Q3 2023 to $67.76 million in Q4 2025 over the past five years.
- Peak year-over-year performance for Total Liabilities in the last five years was growth of 138.5% in Q4 2025, against a decline of 21.7% in Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 87.82 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 65.46 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 83.95 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 37.53 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 115.64 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 7.18 Bn |
| 10 | Larimar Therapeutics | 329.31 Mn | -277.77 Mn | - | 37.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.92 Mn |
| Dec 31, 2025 | 67.76 Mn |
| Sep 30, 2025 | 48.31 Mn |
| Jun 30, 2025 | 30.13 Mn |
| Mar 31, 2025 | 25.90 Mn |
| Dec 31, 2024 | 28.41 Mn |
| Sep 30, 2024 | 20.62 Mn |
| Jun 30, 2024 | 25.76 Mn |
| Mar 31, 2024 | 17.36 Mn |
| Dec 31, 2023 | 14.22 Mn |
| Sep 30, 2023 | 11.24 Mn |
| Jun 30, 2023 | 11.79 Mn |
| Mar 31, 2023 | 12.67 Mn |
| Dec 31, 2022 | 15.50 Mn |
| Sep 30, 2022 | 14.35 Mn |
| Jun 30, 2022 | 12.80 Mn |
| Mar 31, 2022 | 14.12 Mn |
| Dec 31, 2021 | 14.25 Mn |
| Sep 30, 2021 | 15.87 Mn |
| Jun 30, 2021 | 13.41 Mn |
API Access
Larimar Therapeutics Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();